CRVL:NGS-CorVel Corp. (USD)

EQUITY | Insurance Brokers | Nasdaq Global Select

Last Closing

USD 252.1

Change

-2.17 (-0.85)%

Market Cap

USD 0.65B

Volume

0.03M

Analyst Target

USD 0.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

CorVel Corp provides case management, claims administration, and medical bill review services to payors to administer, manage and control the cost of workers compensation and other healthcare benefits.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-01 )

Largest Industry Peers for Insurance Brokers

Symbol Name Price(Change) Market Cap
WTW Willis Towers Watson PLC

-1.76 (-0.67%)

USD 26.83B
ERIE Erie Indemnity Company

-0.85 (-0.23%)

USD 18.95B
GOCO GoHealth Inc.

-0.04 (-0.38%)

USD 0.22B
EHTH eHealth Inc

+0.09 (+2.02%)

USD 0.13B
FANH Fanhua Inc

-0.02 (-1.11%)

USD 0.11B
HUIZ Huize Holding Ltd

+0.01 (+0.97%)

USD 0.05B
RELIW Reliance Global Group Inc

-0.04 (-47.50%)

USD 0.04B
TIRX Tian Ruixiang Holdings Ltd

-0.01 (-0.47%)

USD 5.22M
RELI Reliance Global Group Inc

+0.10 (+2.63%)

USD 3.31M
BWIN The Baldwin Insurance Group, I..

-0.32 (-0.89%)

N/A

ETFs Containing CRVL

JSML Janus Henderson Small Cap.. 3.19 % 0.50 %

+0.19 (+0.32%)

USD 0.22B

Market Performance

  Market Performance vs. Industry/Classification (Insurance Brokers) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.98% 56% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.98% 56% F 58% F
Trailing 12 Months  
Capital Gain 28.67% 78% C+ 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.67% 78% C+ 83% B
Trailing 5 Years  
Capital Gain 183.64% 80% B- 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 183.64% 80% B- 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 36.68% 78% C+ 87% B+
Dividend Return 36.68% 78% C+ 87% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 39.33% 67% D+ 46% F
Risk Adjusted Return 93.26% 100% F 96% N/A
Market Capitalization 0.65B 78% C+ 88% B+

Key Financial Ratios

  Ratio vs. Industry/Classification (Insurance Brokers) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 23.80 14% 17%
Price/Book Ratio 17.32 13% 6%
Price / Cash Flow Ratio 43.98 22% 6%
Price/Free Cash Flow Ratio 32.83 29% 7%
Management Effectiveness  
Return on Equity 33.90% 100% 95%
Return on Invested Capital 33.90% 100% 93%
Return on Assets 14.01% 89% 98%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector